Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Phylum Actinobacteria01:30

Bacterial Phylum Actinobacteria

530
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
530
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

656
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
656
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

720
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
720

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Maternal Vaccine Study Protocol: A Victorian Cohort Study Evaluating Infant and Childhood Safety and Health and Developmental Outcomes After Vaccination Against Respiratory Viruses in Pregnancy.

Vaccines·2026
Same author

Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults.

Infection·2026
Same author

Maternal preferences for infant respiratory syncytial virus (RSV) preventives: an Australian discrete choice experiment.

Vaccine·2026
Same author

Characterizing thunderstorm asthma emergency department presentations using natural language processing for improved real-time surveillance.

American journal of epidemiology·2026
Same author

Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.

Vaccine·2026
Same author

Incidence of Childhood Stroke and Association With Recent Infection: A Population-Based Study Using Linked Data.

Neurology·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.5K

Capsulate bacteria and the lung.

Jim Buttery1, E Richard Moxon

  • 1Oxford Vaccine Group, University Department of Paediatrics, John Radcliffe Hospital, Oxford, UK. jim.buttery@paediatrics.ox.ac.uk

British Medical Bulletin
|May 9, 2002
PubMed
Summary
This summary is machine-generated.

Capsulate bacteria are a major cause of pneumonia worldwide. Vaccines targeting their capsular polysaccharides offer a promising strategy to prevent invasive bacterial diseases in all age groups.

More Related Videos

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
05:52

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient

Published on: January 7, 2019

14.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.5K
Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
05:52

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient

Published on: January 7, 2019

14.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Area of Science:

  • Bacteriology
  • Immunology
  • Vaccinology

Background:

  • Capsulate bacteria are a leading cause of community-acquired pneumonia globally.
  • These bacteria utilize capsular polysaccharides as a key virulence factor to evade phagocytosis.
  • Invasive diseases, including sepsis and meningitis, can arise from these infections.

Purpose of the Study:

  • To highlight the role of capsular polysaccharides in bacterial virulence.
  • To discuss the potential of targeting capsular polysaccharides for vaccine development.
  • To review the impact of existing vaccines on bacterial pneumonia.

Main Methods:

  • Review of scientific literature on capsulate bacteria and pneumonia.
  • Analysis of the role of capsular polysaccharides in pathogenesis.
  • Examination of vaccine development strategies targeting capsular polysaccharides.

Main Results:

  • Capsular polysaccharides are crucial for bacterial survival and evasion of host defenses.
  • Vaccine strategies targeting capsular polysaccharides have shown significant impact.
  • Successes include reductions in Streptococcus pneumoniae and Haemophilus influenzae type b pneumonia.

Conclusions:

  • Capsular polysaccharides represent a viable and effective target for vaccine development.
  • Vaccines offer a powerful tool for preventing invasive bacterial diseases caused by capsulate bacteria.
  • Advancements in vaccinology are crucial for global public health initiatives against pneumonia.